Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

PTIXW
Protagenic Therapeutics Inc - Warrants (13/04/2025)
stock NASDAQ Warrant

At Close
1/24/2023 1:05:30 PM EST
0.0514USD+127.434%(+0.0288)8,500
0.0247Bid   0.0676Ask   0.0429Spread IEX
Pre-market
1969-12-31
0.00USD-100.000%(-0.02)0
After-hours
1969-12-31
0.00USD0.000%(0.00)0
OverviewHistoricalExchange VolumeShort VolumeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
163.452K
Industry
Biotechnology
PTIXW Stats
Avg. Vol. 10 Day
5,760
Avg. Vol. 30 Day
4,466
Market Cap
163,452
Shares Out.
3,180,000
On/Off Exchange
84%/16%
6 Month Beta
-8.56
1 Year Beta
-0.12
2 Year Beta
0.55
52 Week Low
0.01
52 Week High
0.31
SMA50
0.04
SMA200
0.05
1 Week
+127.43%
1 Month
+133.64%
3 Month
-14.19%
6 Month
-37.77%
1 Year
-79.37%
2 Year
-84.42%
Nov 16, 2021
09:58AM EST  Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced results for the third quarter ended September 30, 2021.   GlobeNewswire Inc
Aug 30, 2021
09:15AM EDT  Scientific rationale and evidence for PT00114 in the treatment of Depression, Anxiety, PTSD and Addiction to be discussed   GlobeNewswire Inc
Aug 17, 2021
07:45AM EDT  Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced results for the second quarter ended June 30, 2021.   GlobeNewswire Inc
Jul 23, 2021
04:21PM EDT  Protagenic Therapeutics Updates Timeline for Commencement of   GlobeNewswire Inc
Jul 6, 2021
06:17AM EDT  Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced that it will host a key opinion leader (KOL) webinar focused on PT00114 for the regulation of stress in patients with Depression, PTSD, Anxiety and Addiction on Tuesday, July 13 at 10:00AM ET.   GlobeNewswire Inc
More News
Profile
Protagenic Therapeutics, Inc. operates as a biotechnology company. The Company focuses on the discovery and development of novel and naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. Protagenic Therapeutics offers its services in the United States.

PTIXW Stock Summary

Protagenic Therapeutics Inc - Warrants (13/04/2025) (NASDAQ:PTIXW) stock price today is $0.0514, and today's volume is 8,500. PTIXW is up 127.434% today. The 30 day average volume is 4,466. PTIXW market cap is 163.452K with 3,180,000 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC